Literature DB >> 9040717

Inflammatory myopathy in thyrotoxicosis.

O Hardiman1, F Molloy, F Brett, M Farrell.   

Abstract

A 45-year-old man with a 3-month history of episodic muscle weakness, MRC grade 4/5 symmetric hip flexor weakness, elevated CK, and an inflammatory myopathy was found to have elevated free thyroxine and T3. Treatment with carbimazole resulted in complete resolution of symptoms and return of muscle power to normal. A repeat biopsy revealed resolution of the inflammatory endomysial infiltrate and an absence of necrosis. Complete clinical and pathologic resolution of a thyrotoxicosis-associated inflammatory myopathy without steroid therapy has not been previously described. The favorable outcome experienced by this patient indicates that steroids may not be necessary in thyrotoxicosis-associated inflammatory myopathy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9040717     DOI: 10.1212/wnl.48.2.339

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  2 in total

1.  Anti-thyroid drugs-related myopathy: is carbimazole the real culprit?

Authors:  Chiu Chi Tsang; Wai Shan Hui; Kwun Man Lo; Jonas Hon Ming Yeung; Yuk Lun Cheng
Journal:  Int J Endocrinol Metab       Date:  2015-01-22

Review 2.  Secondary myopathy due to systemic diseases.

Authors:  J Finsterer; W N Löscher; J Wanschitz; S Quasthoff; W Grisold
Journal:  Acta Neurol Scand       Date:  2016-02-25       Impact factor: 3.209

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.